{"title":"[49-year-old male with infected insect bite].","authors":"N. Kellner, Torsten Kraya, Christoph Lübbert","doi":"10.1055/a-2266-8682","DOIUrl":"https://doi.org/10.1055/a-2266-8682","url":null,"abstract":"","PeriodicalId":11370,"journal":{"name":"Deutsche Medizinische Wochenschrift","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140780132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Antithrombotic therapy in acute coronary syndrome].","authors":"Andreas Schäfer","doi":"10.1055/a-2171-6892","DOIUrl":"https://doi.org/10.1055/a-2171-6892","url":null,"abstract":"Dual antiplatelet therapy (DAPT) is the cornerstone of maintenance medication following acute coronary syndromes (ST elevation myocardial infarction, non-ST elevation myocardial infarction, unstable angina). Over the last decade, P2Y12 inhibition in addition to low-dose acetylsalicylic acid has been intensively debated. In patients with acute coronary syndromes, balancing the reduction in cardiovascular events and increase in major bleeding during treatment with more potent P2Y12 inhibitors such as prasugrel and ticagrelor is still an issue. A special focus is on patients already treated with oral anticoagulants for stroke prevention in atrial fibrillation who require additional platelet inhibition following coronary stenting. This article summarizes the major recommendations given in the most recent Guideline for \"Acute Coronary Syndromes\" published by the European Society of Cardiology (ESC). The recommendations finally address strategies to reduce an increased bleeding risk based on clinical predictors.","PeriodicalId":11370,"journal":{"name":"Deutsche Medizinische Wochenschrift","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140766164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Demenz: Erhöhtes Risiko durch Hormontherapie in den Wechseljahren?","authors":"","doi":"10.1055/a-2125-4658","DOIUrl":"https://doi.org/10.1055/a-2125-4658","url":null,"abstract":"Weltweit sind heute mehr Frauen als Männer von einer demenziellen Erkrankung betroffen. Auf der Suche nach möglichen Risikofaktoren auf Seiten des weiblichen Geschlechts haben Pourhadi et al. daher nun die Auswirkungen einer Hormontherapie (HT) während der Wechseljahre untersucht und kommen in ihrer nationalen Fall-Kontroll-Studie zu einem überraschenden Ergebnis.","PeriodicalId":11370,"journal":{"name":"Deutsche Medizinische Wochenschrift","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135370341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Nephrologie: Leichte eGFR-Reduktion als Risikofaktor bei jungen Erwachsenen?","authors":"","doi":"10.1055/a-2125-4615","DOIUrl":"https://doi.org/10.1055/a-2125-4615","url":null,"abstract":"Obgleich eine geschätzte glomeruläre Filtrationsrate (eGFR) von unter 60ml/min/1,73m2 über mindestens 90 Tage als Hinweis für den Beginn einer Nierenerkrankung gilt, sind etwaige altersabhängige Zusammenhänge zwischen geringfügigen Einschränkungen der Nierenfunktion und dem Risiko für unerwünschte Ereignisse bis heute immer noch unklar. Hussain et al. wollten daher eine Lücke schließen und haben eine entsprechende Kohortenstudie initiiert.","PeriodicalId":11370,"journal":{"name":"Deutsche Medizinische Wochenschrift","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135370239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Gentherapie für Patienten mit Hämophilie B ist Faktor-IX-Gabe überlegen","authors":"","doi":"10.1055/a-2043-7504","DOIUrl":"https://doi.org/10.1055/a-2043-7504","url":null,"abstract":"Die lebenslange regelmäßige intravenöse Substitution des Gerinnungsfaktors IX ist die bisher einzige Therapieoption bei der Hämophilie B, einer seltenen, nur bei Männern manifesten Erkrankung, bei der es durch den Faktor-IX-Mangel unter anderem zu spontanen Muskel- und Gelenkeinblutungen kommt. Eine innovative Gentherapie könnte der „Gamechanger“ bei der Erkrankung sein, wie eine aktuelle Phase-3-Studie zeigte.","PeriodicalId":11370,"journal":{"name":"Deutsche Medizinische Wochenschrift","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135609827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Bei Lungenkrankheiten schlagen Radiologen die KI","authors":"","doi":"10.1055/a-1986-2599","DOIUrl":"https://doi.org/10.1055/a-1986-2599","url":null,"abstract":"Drug Prescribing for Patients with Chronic Kidney Disease in General Practice: a Cross-Sectional Study","PeriodicalId":11370,"journal":{"name":"Deutsche Medizinische Wochenschrift","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135609828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Covid-19: Algorithmus zur Risikoprognose während der Omicron-Welle","authors":"","doi":"10.1055/a-2125-4539","DOIUrl":"https://doi.org/10.1055/a-2125-4539","url":null,"abstract":"Nicht alle während der Coronapandemie mit SARS-CoV-2 infizierten Menschen entwickelten schwere Verläufe bis hin zum Tod oder mussten im Krankenhaus behandelt werden. Hippisley-Cox et al. haben daher auf Basis von nationalen Daten mit Erhebung während der Omicron-Welle in England einen Algorithmus zur Prognose von Tod und Hospitalisation entwickelt und berücksichtigten dabei vor allem die Anzahl stattgehabter COVID-19-Impfungen.","PeriodicalId":11370,"journal":{"name":"Deutsche Medizinische Wochenschrift","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135370339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Suizidrisiko bei medizinischem Personal","authors":"","doi":"10.1055/a-1986-2641","DOIUrl":"https://doi.org/10.1055/a-1986-2641","url":null,"abstract":"Drug Prescribing for Patients with Chronic Kidney Disease in General Practice: a Cross-Sectional Study","PeriodicalId":11370,"journal":{"name":"Deutsche Medizinische Wochenschrift","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135566226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Welche Adipositasmarker korrelieren mit Mortalität?","authors":"","doi":"10.1055/a-1986-2627","DOIUrl":"https://doi.org/10.1055/a-1986-2627","url":null,"abstract":"Drug Prescribing for Patients with Chronic Kidney Disease in General Practice: a Cross-Sectional Study","PeriodicalId":11370,"journal":{"name":"Deutsche Medizinische Wochenschrift","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135566214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Ischämischer Apoplex bei Vorhofflimmern: Frühe Antikoagulation mit Benefit?","authors":"","doi":"10.1055/a-2125-4496","DOIUrl":"https://doi.org/10.1055/a-2125-4496","url":null,"abstract":"Nach einem ischämischen Schlaganfall bei Vorhofflimmern kommen heute direkte orale Antikoagulantien (DOAKs) regelhaft zum Einsatz. Dabei gibt es aktuell nur wenige Studien und Erkenntnisse darüber, ob ein früher oder ein später Therapiebeginn mit einem besseren Behandlungsergebnis einhergehen könnten. Fischer et al. wollten in diesem Kontext eine Wissenslücke schließen und haben eine prospektive Studie zum Thema durchgeführt.","PeriodicalId":11370,"journal":{"name":"Deutsche Medizinische Wochenschrift","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135566215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
